Lawrence Kaplan

585 total citations
14 papers, 195 citations indexed

About

Lawrence Kaplan is a scholar working on Pathology and Forensic Medicine, Oncology and Infectious Diseases. According to data from OpenAlex, Lawrence Kaplan has authored 14 papers receiving a total of 195 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 5 papers in Oncology and 3 papers in Infectious Diseases. Recurrent topics in Lawrence Kaplan's work include Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and CAR-T cell therapy research (3 papers). Lawrence Kaplan is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and CAR-T cell therapy research (3 papers). Lawrence Kaplan collaborates with scholars based in United States, Türkiye and Canada. Lawrence Kaplan's co-authors include Barry J. Evans, David Fleece, Stephen C. Aronoff, Brandelyn N. Pitcher, Sin‐Ho Jung, Jeffrey M. Venstrom, Juan Du, Jeffrey L. Johnson, Lewis L. Lanier and Myron S. Czuczman and has published in prestigious journals such as Blood, Journal of General Internal Medicine and Radiographics.

In The Last Decade

Lawrence Kaplan

13 papers receiving 194 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lawrence Kaplan United States	8	73	51	50	45	37	14	195
Cameron Shaw Australia	7	40 0.5×	11 0.2×	95 1.9×	54 1.2×	29 0.8×	19	206
Thomas Baehring Germany	8	66 0.9×	107 2.1×	10 0.2×	70 1.6×	55 1.5×	19	289
Paulie Papavassiliou United States	8	48 0.7×	25 0.5×	39 0.8×	78 1.7×	18 0.5×	10	315
Kathy R. Hogan United States	8	124 1.7×	33 0.6×	22 0.4×	50 1.1×	23 0.6×	9	334
Elliott Lever United Kingdom	10	46 0.6×	48 0.9×	25 0.5×	38 0.8×	30 0.8×	18	336
Tania Nicole Masmas Denmark	11	28 0.4×	108 2.1×	10 0.2×	23 0.5×	41 1.1×	27	300
Nitya Gulati United States	9	43 0.6×	22 0.4×	38 0.8×	8 0.2×	75 2.0×	22	339
Adam DuVall United States	10	74 1.0×	15 0.3×	17 0.3×	91 2.0×	13 0.4×	44	244
Kathryn Connelly Australia	10	23 0.3×	73 1.4×	30 0.6×	17 0.4×	24 0.6×	18	223
Sue Deiling United States	10	37 0.5×	54 1.1×	21 0.4×	21 0.5×	17 0.5×	21	332

Countries citing papers authored by Lawrence Kaplan

Since Specialization

Citations

This map shows the geographic impact of Lawrence Kaplan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Kaplan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Kaplan more than expected).

Fields of papers citing papers by Lawrence Kaplan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence Kaplan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Kaplan. The network helps show where Lawrence Kaplan may publish in the future.

Co-authorship network of co-authors of Lawrence Kaplan

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence Kaplan. A scholar is included among the top collaborators of Lawrence Kaplan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence Kaplan. Lawrence Kaplan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Banerjee, Rahul, Victoria Wang, Chiung‐Yu Huang, et al.. (2023). Hypoxia-specific imaging in patients with lymphoma undergoing CAR-T therapy. European Journal of Nuclear Medicine and Molecular Imaging. 50(11). 3349–3353. 1 indexed citations

Sağlam, Arzu, Jyoti Kumar, Soham Mukherjee, et al.. (2022). Copy Number Loss at Chromosome 14q11.2 Correlates With the Proportion of T Cells in Biopsies and Helps Identify T-Cell Neoplasms. Archives of Pathology & Laboratory Medicine. 147(8). 940–948.

Weaver, Eric, et al.. (2021). UCSF End-of-Life Option Act 2016–2019: A Retrospective Chart Review Pilot (SCI923). Journal of Pain and Symptom Management. 61(3). 682–682. 1 indexed citations

Ramos, Juan Carlos, Joseph A. Sparano, Amy Chadburn, et al.. (2020). Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial). Blood. 136(11). 1284–1297. 36 indexed citations

Bourgeois, James A., et al.. (2018). Physician-Assisted Death Psychiatric Assessment: A Standardized Protocol to Conform to the California End of Life Option Act. Psychosomatics. 59(5). 441–451. 9 indexed citations

Kaplan, Lawrence, et al.. (2018). Palatal Mucormycosis. Journal of General Internal Medicine. 33(10). 1815–1815. 2 indexed citations

Du, Juan, Sandra López‐Vergès, Brandelyn N. Pitcher, et al.. (2014). CALGB 150905 (Alliance): Rituximab Broadens the Antilymphoma Response by Activating Unlicensed NK Cells. Cancer Immunology Research. 2(9). 878–889. 44 indexed citations

Noy, Ariela, Lawrence Kaplan, Jeannette Y. Lee, Ethel Cesarman, & Wayne Tam. (2012). Modified dose intensive R- CODOX-M/IVAC for HIV-associated burkitt (BL) (AMC 048) shows efficacy and tolerability, and predictive potential of IRF4/MUM1 expression. Infectious Agents and Cancer. 7(S1). 4 indexed citations

Aronoff, Stephen C., et al.. (2010). Integrating Evidence Based Medicine Into Undergraduate Medical Education: Combining Online Instruction With Clinical Clerkships. Teaching and Learning in Medicine. 22(3). 219–223. 56 indexed citations

10.

Martin, Thomas, Lloyd E. Damon, Lawrence Kaplan, et al.. (2009). Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation. Transplant Infectious Disease. 12(1). 45–50. 18 indexed citations

11.

Koç, Omer N., Charles H. Redfern, Peter H. Wiernik, et al.. (2005). Extended Follow-Up and Analysis with Central Radiological Review of Patients Receiving FavId® (Id/KLH) Vaccine Following Rituximab.. Blood. 106(11). 772–772. 7 indexed citations

12.

Koç, Omer N., Charles H. Redfern, Peter H. Wiernik, et al.. (2004). Id/KLH Vaccine (FavId™) Following Treatment with Rituximab: An Analysis of Response Rate Improvement (RRI) and Time-to-Progression (TTP) in Follicular Lymphoma (FL).. Blood. 104(11). 587–587. 8 indexed citations

13.

Kaplan, Lawrence, et al.. (1984). Amiodarone-induced corneal deposits.. PubMed. 16(8). 762–66. 7 indexed citations

14.

Miller, Kenneth D., et al.. (1982). The radiology of male impotence. Radiographics. 2(2). 131–152. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact